| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c10198612d81460a790c33ba7a6b11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_169a79c4ca869496948acde710269910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e4905f2e170264d711861e7d17dd82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9742ea188614c8cc92888ca1f0ee263a |
| publicationDate |
2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210114717-A |
| titleOfInvention |
A Composition for Preventing or Treating Metabolic Disorders Comprising a Tat Peptide Variant as an Active Ingredient |
| abstract |
The present invention relates to a pharmaceutical composition and a functional food composition for the prevention or treatment of metabolic diseases comprising, as an active ingredient, a Tat peptide variant in which an internal residue of a certain length is substituted with an aliphatic amino carboxylic acid. The composition of the present invention can be usefully used as a composition for treating metabolic diseases that is easier to produce and has superior biocompatibility because water solubility and yield are remarkably increased while maintaining the fat reduction effect of the natural Tat peptide. |
| priorityDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |